SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,151.04 905.01
( 1.24%)

Global Indices

Nasdaq

52,520.99 122.42
(0.23%)

Dow Jones

7,766.26 22.66
(0.29%)

Hang Seng

64,627.45 673.26
(1.05%)

Nikkei 225

10,729.94 35.44
(0.33%)

Forex

USD-INR

95.08 -0.03
(-0.03%)

EUR-INR

106.01 -0.48
(-0.45%)

GBP-INR

126.67 -0.36
(-0.28%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Symbiotec Pharmalab Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544889

INE899I01028

195.2322192

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYMBIOTEC

52.51

8186.23

EPS(TTM)

Face Value()

Div & Yield %

24.26

Back

j l morison (india) ltd

Venky's (India) standalone net profit rises 215.79% in the June 2026 quarter

Aug 11,2026

Net profit of Venky's (India) rose 215.79% to Rs 49.99 crore in the quarter ended June 2026 as against Rs 15.83 crore during the previous quarter ended June 2025. Sales rose 29.17% to Rs 1118.38 crore in the quarter ended June 2026 as against Rs 865.83 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1118.38	865.83	29
OPM %	6.18	2.72	-
PBDT	78.72	30.98	154
PBT	69.27	21.77	218
NP	49.99	15.83	216

74,151.04 905.01 ( 1.24%)

52,520.99 122.42 (0.23%)

7,766.26 22.66 (0.29%)

64,627.45 673.26 (1.05%)

10,729.94 35.44 (0.33%)

95.08 -0.03 (-0.03%)

106.01 -0.48 (-0.45%)

126.67 -0.36 (-0.28%)

0.60 0.00 (-0.36%)